antibody clone ve1 (Spring Bioscience)
86
Structured Review
Spring Bioscience
antibody clone ve1
Antibody Clone Ve1, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ve1+antibody/anti+braf+v600e/pm40815143-8-6-7
Average 86 stars, based on 1 article reviews
Antibody Clone Ve1, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ve1+antibody/anti+braf+v600e/pm40815143-8-6-7
Average 86 stars, based on 1 article reviews
antibody clone ve1 - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Polymerase Chain Reaction:Article Title: BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma. Article Snippet: Background.. Previous literatures showed wide range of prevalence of BRAF V600E in papillary thyroid carcinoma (PTC).. The correlation of BRAF V600E mutation with aggressive tumor characteristics and poor prognosis is controversial. Sequencing:Article Title: BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma. Article Snippet: Background.. Previous literatures showed wide range of prevalence of BRAF V600E in papillary thyroid carcinoma (PTC).. The correlation of BRAF V600E mutation with aggressive tumor characteristics and poor prognosis is controversial. Article Title: A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases. Article Snippet: Most studies for comprehensive molecular profiling of papillary thyroid carcinoma (PTC) have been performed before the 2017 World Health Organization (WHO) classification, in which the diagnostic criteria of follicular variants of PTC have been modified and noninvasive follicular thyroid neoplasm with papillary-like nuclear features has been introduced.. This study aims to investigate the shift in the incidence of BRAF V600E mutations in PTCs following the 2017 WHO classification and to further characterize the histologic subtypes and molecular drivers in BRAF-negative cases.. The study cohort consisted of 554 consecutive PTCs larger than 0.5 cm between January 2019 and May 2022. Immunohistochemical staining:Article Title: BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma. Article Snippet: Background.. Previous literatures showed wide range of prevalence of BRAF V600E in papillary thyroid carcinoma (PTC).. The correlation of BRAF V600E mutation with aggressive tumor characteristics and poor prognosis is controversial. Article Title: Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation Article Snippet: .. Immunohistochemical analysis was performed on all cases utilizing the other:Article Title: BRAFV600E and MAP2K1 mutations in Langerhans cell histiocytosis occur predominantly in children. Article Snippet: Department of Pathology, State Key Laboratory of Cancer Biology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China Department of Pathology, School of Medicine, Kurume University, Kurume, Fukuoka, Japan Correspondence Ying Guo, Department of Pathology, Xijing Hospital, Preclinical School, Fourth Military Medical University, Changlexi Street No.169, Xi'an City, Shaanxi Province, China.. Email: guoying@fmmu.edu.cn Article Title: Giant cell glioblastoma is a distinctive subtype of glioma characterized by vulnerability to DNA damage Article Snippet: Immunohistochemistry (IHC) using a Leica BOND-III (Leica, Newcastle Upon Tyne, UK) after antigen retrieval on 4-μm-thick FFPE sections was conducted using antibodies against IDH1 (H09, 1:200; Dianova, Hamburg, Germany), ATRX (polyclonal, 1:1000; ATRAS Antibodies, Stockholm, Sweden), Mutagenesis:Article Title: Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation Article Snippet: .. Immunohistochemical analysis was performed on all cases utilizing the Article Title: Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2 Article Snippet: Polymerase chain reaction is used to amplify the region and the degree of methylation of four CpG sites is analysed in a single pyrosequencing reaction by taking the average of four sites. .. In cases where only biopsy tissue was available and MLH1 -hm testing failed, BRAF immunohistochemistry for the V600E mutation was performed as previously described using the Immunohistochemistry:Article Title: A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases. Article Snippet: Most studies for comprehensive molecular profiling of papillary thyroid carcinoma (PTC) have been performed before the 2017 World Health Organization (WHO) classification, in which the diagnostic criteria of follicular variants of PTC have been modified and noninvasive follicular thyroid neoplasm with papillary-like nuclear features has been introduced.. This study aims to investigate the shift in the incidence of BRAF V600E mutations in PTCs following the 2017 WHO classification and to further characterize the histologic subtypes and molecular drivers in BRAF-negative cases.. The study cohort consisted of 554 consecutive PTCs larger than 0.5 cm between January 2019 and May 2022. Article Title: Immunohistochemical detection of the BRAF V600E mutant protein in colorectal cancers in Taiwan is highly concordant with the molecular test. Article Snippet: Aims: The aims of this study were to investigate the incidence of BRAF mutations in colorectal cancers (CRCs) in Taiwan and the sensitivity and specificity of VE1 immunohistochemistry in detecting the BRAF mutation.. Methods and results: A total of 425 resected colorectal adenocarcinoma specimens were recruited into this study.. Direct Sanger sequencing of exon 15 of the BRAF gene was performed for all cases. Article Title: Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon Article Snippet: .. BRAF immunohistochemistry Six cases (Cases #1, 2, 3, 4, 6, and 7) with available material were subjected to immunohistochemistry analysis using the Article Title: Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2 Article Snippet: Polymerase chain reaction is used to amplify the region and the degree of methylation of four CpG sites is analysed in a single pyrosequencing reaction by taking the average of four sites. .. In cases where only biopsy tissue was available and MLH1 -hm testing failed, BRAF immunohistochemistry for the V600E mutation was performed as previously described using the Staining:Article Title: A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases. Article Snippet: Most studies for comprehensive molecular profiling of papillary thyroid carcinoma (PTC) have been performed before the 2017 World Health Organization (WHO) classification, in which the diagnostic criteria of follicular variants of PTC have been modified and noninvasive follicular thyroid neoplasm with papillary-like nuclear features has been introduced.. This study aims to investigate the shift in the incidence of BRAF V600E mutations in PTCs following the 2017 WHO classification and to further characterize the histologic subtypes and molecular drivers in BRAF-negative cases.. The study cohort consisted of 554 consecutive PTCs larger than 0.5 cm between January 2019 and May 2022. Article Title: Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2 Article Snippet: Polymerase chain reaction is used to amplify the region and the degree of methylation of four CpG sites is analysed in a single pyrosequencing reaction by taking the average of four sites. .. In cases where only biopsy tissue was available and MLH1 -hm testing failed, BRAF immunohistochemistry for the V600E mutation was performed as previously described using the Next-Generation Sequencing:Article Title: A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases. Article Snippet: Most studies for comprehensive molecular profiling of papillary thyroid carcinoma (PTC) have been performed before the 2017 World Health Organization (WHO) classification, in which the diagnostic criteria of follicular variants of PTC have been modified and noninvasive follicular thyroid neoplasm with papillary-like nuclear features has been introduced.. This study aims to investigate the shift in the incidence of BRAF V600E mutations in PTCs following the 2017 WHO classification and to further characterize the histologic subtypes and molecular drivers in BRAF-negative cases.. The study cohort consisted of 554 consecutive PTCs larger than 0.5 cm between January 2019 and May 2022. Incubation:Article Title: Immunohistochemical detection of the BRAF V600E mutant protein in colorectal cancers in Taiwan is highly concordant with the molecular test. Article Snippet: Aims: The aims of this study were to investigate the incidence of BRAF mutations in colorectal cancers (CRCs) in Taiwan and the sensitivity and specificity of VE1 immunohistochemistry in detecting the BRAF mutation.. Methods and results: A total of 425 resected colorectal adenocarcinoma specimens were recruited into this study.. Direct Sanger sequencing of exon 15 of the BRAF gene was performed for all cases. Article Title: Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2 Article Snippet: Polymerase chain reaction is used to amplify the region and the degree of methylation of four CpG sites is analysed in a single pyrosequencing reaction by taking the average of four sites. .. In cases where only biopsy tissue was available and MLH1 -hm testing failed, BRAF immunohistochemistry for the V600E mutation was performed as previously described using the Polymer:Article Title: Immunohistochemical detection of the BRAF V600E mutant protein in colorectal cancers in Taiwan is highly concordant with the molecular test. Article Snippet: Aims: The aims of this study were to investigate the incidence of BRAF mutations in colorectal cancers (CRCs) in Taiwan and the sensitivity and specificity of VE1 immunohistochemistry in detecting the BRAF mutation.. Methods and results: A total of 425 resected colorectal adenocarcinoma specimens were recruited into this study.. Direct Sanger sequencing of exon 15 of the BRAF gene was performed for all cases. |
